Thomson Medical Group Ltd. (A50) AI Stock Analysis

• Market Cap: S$1.61B
• Dividend Yield: N/A
• Average Volume (3M): 7.77M
• Price to Earnings (P/E): ―
• Beta (1Y): 0.70
• Revenue Growth: 12.39%
• EPS Growth: -400.00%
• Country: SG
• Employees: 699
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Care Facilities
• EPS (TTM): >-0.01
• Shares Outstanding: 26,441,066,000
• 10 Day Avg. Volume: 7,056,060
• 30 Day Avg. Volume: 7,771,663
• PEG Ratio: 0.05
• Price to Book (P/B): 2.41
• Price to Sales (P/S): 2.88
• P/FCF Ratio: 33.65
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: S$0.08
• Price Target Upside: 25.87% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 49 Neutral
• Price Target: S$0.00 ▼(-100.00% Downside)

Thomson Medical Group Ltd. has a low overall stock score due to significant financial challenges, including declining revenues, high leverage, and cash flow issues. The technical analysis provides some moderate support with short-term bullish momentum, but the valuation is unattractive due to a negative P/E ratio and lack of dividend yield.

Thomson Medical Group Ltd. Business Overview & Revenue Model

Company Description

Thomson Medical Group Ltd. (A50) is a leading healthcare service provider in Singapore, specializing in the provision of medical services, healthcare facilities, and the development of healthcare-related businesses. The company operates a network of hospitals and clinics, focusing on women's and children's health, as well as a range of other medical specialties. Thomson Medical Group is committed to delivering high-quality healthcare solutions through comprehensive services that include inpatient and outpatient care, diagnostic services, and health screening programs.

How the Company Makes Money

Thomson Medical Group generates revenue primarily through its hospital and clinic operations, where it charges for medical consultations, treatments, surgeries, and other healthcare services. Key revenue streams include patient admissions, outpatient services, diagnostic imaging, and laboratory tests. The group also benefits from ancillary services such as pharmacy sales and health screening packages. Additionally, Thomson Medical Group engages in strategic partnerships and collaborations with other healthcare providers and organizations, enhancing its service offerings and expanding its market reach. These partnerships, along with a focus on quality care and patient satisfaction, contribute significantly to its earnings.

Thomson Medical Group Ltd. Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	455.53M	394.66M	351.15M	355.77M	333.71M	240.40M
Gross Profit	220.71M	295.33M	275.39M	296.39M	278.38M	116.02M
EBITDA	41.73M	57.72M	109.08M	106.78M	110.72M	59.54M
Net Income	-47.58M	-47.58M	14.16M	36.55M	53.76M	14.24M
Balance Sheet
Total Assets	1.78B	1.78B	1.81B	1.45B	1.36B	1.29B
Cash, Cash Equivalents and Short-Term Investments	124.21M	124.21M	167.28M	286.59M	161.59M	114.51M
Total Debt	1.12B	1.12B	1.12B	762.79M	642.86M	631.08M
Total Liabilities	1.24B	1.24B	1.23B	872.34M	756.60M	719.74M
Stockholders Equity	470.89M	470.89M	499.72M	499.44M	531.68M	489.84M
Cash Flow
Free Cash Flow	37.86M	33.79M	52.99M	75.81M	64.68M	23.96M
Operating Cash Flow	60.45M	60.45M	83.35M	88.59M	92.80M	61.25M
Investing Cash Flow	-27.16M	-27.16M	-489.99M	-13.39M	-29.44M	-37.57M
Financing Cash Flow	-71.19M	-71.19M	281.32M	54.22M	-23.48M	-58.82M

Thomson Medical Group Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.06
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:A50, the sentiment is Positive. The current price of 0.06 is below the 20-day moving average (MA) of 0.06, above the 50-day MA of 0.06, and above the 200-day MA of 0.05, indicating a bullish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 56.12 is Neutral, neither overbought nor oversold. The STOCH value of 56.19 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:A50.

Thomson Medical Group Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
A50	49 Neutral	S$1.61B	―	-9.99%	―	12.39%	-400.00%

Thomson Medical Group Ltd. Corporate Events

Thomson Medical Group Adopts Market Capitalisation for Materiality Thresholds

Thomson Medical Group Ltd. has announced a change in its method for calculating materiality thresholds due to its negative net tangible asset position as of June 2025. The company will now use market capitalisation as a reference point, which has been approved by the Singapore Exchange Securities Trading Limited, to better reflect the business’s scale and valuation for the financial year ending June 2026.

Thomson Medical Group Unveils Johor Bay Mega Project

Thomson Medical Group has announced the launch of the Johor Bay Mega Project, a 26-acre development with a projected gross development value of over MYR18 billion. This integrated project will feature a mix of healthcare facilities, luxury residences, hospitality, and commercial lifestyle elements, aiming to capitalize on Johor’s strategic location and economic potential. The development is expected to significantly impact the region’s skyline and economy, leveraging the area’s high living standards and the upcoming completion of key infrastructure projects like the RTS.

The most recent analyst rating on (SG:A50) stock is a Buy with a S$0.06 price target. To see the full list of analyst forecasts on Thomson Medical Group Ltd. stock, see the SG:A50 Stock Forecast page.

Thomson Medical Secures S$225 Million Islamic Credit Facility

Thomson Medical Group Limited has secured a S$225 million Islamic revolving credit facility with the option to convert it into a sustainability-linked facility. This marks the company’s first Islamic-linked loan, and the funds will be used to repay existing debts and support the group’s working capital, capital expenditure, business acquisitions, and other corporate purposes. The agreement includes provisions for maintaining its listing on the Singapore Exchange and conditions for early settlement if control over certain subsidiaries changes.

The most recent analyst rating on (SG:A50) stock is a Buy with a S$0.06 price target. To see the full list of analyst forecasts on Thomson Medical Group Ltd. stock, see the SG:A50 Stock Forecast page.